HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chun Ho Lee Selected Research

(3- (4- (2(4- (4chloro- phenyl)- 3,6- dihydro- 2H- pyridin- 1- yl)- ethoxy)- phenyl)- (2S)- ethoxy- propionic acid)

10/2008PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chun Ho Lee Research Topics

Disease

2Insulin Resistance
05/2009 - 10/2008
1Body Weight (Weight, Body)
01/2013
1Type 2 Diabetes Mellitus (MODY)
01/2013
1Hepatocellular Carcinoma (Hepatoma)
10/2008

Drug/Important Bio-Agent (IBA)

2LipidsIBA
01/2013 - 10/2008
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
05/2009 - 10/2008
1Blood Glucose (Blood Sugar)IBA
01/2013
1GlucokinaseIBA
01/2013
1benzamideIBA
01/2013
1YH-GKAIBA
01/2013
1PPAR gammaIBA
05/2009
1Insulin (Novolin)FDA Link
10/2008
1Glucose (Dextrose)FDA LinkGeneric
10/2008
1PPAR alphaIBA
10/2008
1(3- (4- (2(4- (4chloro- phenyl)- 3,6- dihydro- 2H- pyridin- 1- yl)- ethoxy)- phenyl)- (2S)- ethoxy- propionic acid)IBA
10/2008